Cresco Labs (CRLBF) Interest & Investment Income (2019 - 2026)
Cresco Labs (CRLBF) reported Interest & Investment Income of -$14.9 million for Q1 2026, little changed on a YoY basis from -$15.0 million in Q1 2025, and down 4.65% quarter-over-quarter from -$14.3 million in Q4 2025.
Cresco Labs (CRLBF) Interest & Investment Income (2019 - 2026) Analysis & Trends
Cresco Labs has reported Interest & Investment Income for 8 years, with the latest figure at -$14.9 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income changed 0.49% year-over-year to -$14.9 million; the trailing twelve-month figure through Mar 2026 stood at -$14.9 million (changed 0.49% YoY), and the FY2025 full-year result was -$14.3 million, down 9.06% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$14.9 million, down from -$14.3 million in the prior quarter.
- The five-year high for Interest & Investment Income was -$12.6 million in Q2 2025, with the low at -$60.8 million in Q4 2023.
- Historically, Interest & Investment Income has averaged -$29.1 million across 5 years, with a median of -$26.4 million in 2022.
- Annual changes were most pronounced in 2023 — Interest & Investment Income tumbled 31.64% — and 2024, when it surged 78.5%.
- Cresco Labs' Interest & Investment Income stood at -$57.8 million in 2022, then retreated by 5.16% to -$60.8 million in 2023, then surged by 78.5% to -$13.1 million in 2024, then fell by 9.06% to -$14.3 million in 2025, then declined by 4.65% to -$14.9 million in 2026.
- The last three Interest & Investment Income figures came in at -$14.9 million (Q1 2026), -$14.3 million (Q4 2025), and -$42.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Cresco Labs | - | - | 75.45 Mn | -14.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.93 Mn |
| Dec 31, 2025 | -14.26 Mn |
| Sep 30, 2025 | -41.95 Mn |
| Jun 30, 2025 | -12.56 Mn |
| Mar 31, 2025 | -14.85 Mn |
| Dec 31, 2024 | -13.08 Mn |
| Sep 30, 2024 | -42.90 Mn |
| Jun 30, 2024 | -27.88 Mn |
| Mar 31, 2024 | -14.07 Mn |
| Dec 31, 2023 | -60.82 Mn |
| Sep 30, 2023 | -46.49 Mn |
| Jun 30, 2023 | -34.72 Mn |
| Mar 31, 2023 | -15.55 Mn |
| Dec 31, 2022 | -57.84 Mn |
| Sep 30, 2022 | -41.93 Mn |
| Jun 30, 2022 | -26.38 Mn |
| Mar 31, 2022 | -14.36 Mn |
| Dec 31, 2021 | -51.21 Mn |
| Sep 30, 2021 | -36.36 Mn |
| Jun 30, 2021 | -22.78 Mn |